2014
DOI: 10.9734/bjmmr/2014/6863
|View full text |Cite
|
Sign up to set email alerts
|

Burden and Pattern of Cancer in the Sudan, 2000-2006

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 14 publications
0
7
0
Order By: Relevance
“…According to Globocan, about two million new cases were diagnosed in the United States in 2018 with expected deaths of 626,679 [ 3 ]. BC incidence increases in North Sudan tribes, with 16.3% in Galyean, 6.6% in Shygea, and 5.3% in Danagala [ 4 ]. Women living in rural areas in Sudan constituted 58% of individuals presented with BC than those in urban areas [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…According to Globocan, about two million new cases were diagnosed in the United States in 2018 with expected deaths of 626,679 [ 3 ]. BC incidence increases in North Sudan tribes, with 16.3% in Galyean, 6.6% in Shygea, and 5.3% in Danagala [ 4 ]. Women living in rural areas in Sudan constituted 58% of individuals presented with BC than those in urban areas [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…The incidence rate of ovarian cancer in the entire Sudan has yet to be identified; however, in a hospital-based data set from the National Cancer Institute, Gezira University, Central Sudan and Radiation Isotopes Center in Khartoum, collected between 2000 and 2006, ovarian cancer accounted for 6.8% (949) of all recorded cancers (n=226,652), and it was ranked the sixth most common cancer for both genders (3). Additionally, in a more recent data set (2009)(2010)) from the National Cancer Registry for Khartoum State alone, ovarian cancer was the fourth most common cancer in women, with an estimated incidence rate of 188 per 100,000 population, a gender-specific rate of 8.0 per 100,000 population, and an age-standardized rate (ASR) of 7.0 per 100,000 population (4).…”
Section: Introductionmentioning
confidence: 99%
“…The most important benefits are that FNA is a simple, safe and cost-effective first-line method to investigate thyroid lesions, particularly in low-resource settings such as Sudan, in which most of the patients suffering from thyroid lesions presented late to the clinics due to their low-income status. Furthermore, the diagnosis of benign lesions is 50-fold that of malignant ones; this can be interpreted as an increase in the community awareness about thyroid diseases as well as more clinicians recognizing the utility of FNA in evaluating thyroid nodule 57,58 . However, further studies considering this increase in benign lesions showed be well investigated in respect to all factors associated with developing benign thyroid lesions.…”
Section: Discussionmentioning
confidence: 99%